Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation
- PMID: 24872007
- DOI: 10.1097/RLI.0000000000000072
Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation
Abstract
Objectives: The purpose of this study was to assess the association between the serial number of gadolinium-enhanced magnetic resonance imaging (MRI) examinations and the signal hyperintensity of the dentate nucleus on unenhanced T1-weighted images in patients with multiple sclerosis (MS) and those with brain metastases (BMs).
Materials and methods: A group of 38 patients with MS and 37 patients with BM who had undergone at least 2 consecutive enhanced MRI examinations in our institution were examined for this retrospective observational study. The average T1 signal intensity of the dentate nuclei and the pons was obtained, and the dentate nuclei-to-pons (DNP) signal intensity ratio was calculated. These values were compared between patients with less than 6 and 6 enhanced MRI scans or more (eMRI). Relative changes of the DNP were plotted against the number of enhanced MRI scans (eMRIn).
Results: A progressive increase in the T1 signal intensity of the DNP ratio was observed both in the MS group and in the BM group. The DNP ratios of the last eMRI scans in the subgroup of patients with 6 eMRI scans or more were significantly higher than those of the first eMRI scan in the MS group (P < 0.001) and in the BM group (P < 0.01). Relative changes of the DNP showed a positive correlation with the eMRIn with a Spearman ρ of 0.96 (P < 0.001) in the MS group and that of 0.88 (P < 0.001) in the BM group. Curve regression analyses of the relative change of DNP ratios showed linear models to best fit the data with r(2) of 0.89 in the MS group and r(2) of 0.74 in the BM group.
Conclusions: Our study shows that the increase in the unenhanced T1 signal intensity has a linear relationship with the eMRIn in patients with MS and BM. Indeed, we estimated a linear regression model to fit the progressive increase in T1 signal intensity of the dentate nucleus after multiple enhanced MRI scans. This finding suggests substantial dechelation of gadodiamide in patients with normal renal function, raising further concerns regarding the stability of this agent. Further comparative studies with other gadolinium chelates, specifically both linear and macrocyclic, are strongly recommended.
Similar articles
-
High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents.Radiology. 2015 Sep;276(3):836-44. doi: 10.1148/radiol.2015150872. Epub 2015 Jun 16. Radiology. 2015. PMID: 26079490
-
High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.Radiology. 2014 Mar;270(3):834-41. doi: 10.1148/radiol.13131669. Epub 2013 Dec 7. Radiology. 2014. PMID: 24475844
-
Gadodiamide and Dentate Nucleus T1 Hyperintensity in Patients With Meningioma Evaluated by Multiple Follow-Up Contrast-Enhanced Magnetic Resonance Examinations With No Systemic Interval Therapy.Invest Radiol. 2015 Jul;50(7):470-2. doi: 10.1097/RLI.0000000000000154. Invest Radiol. 2015. PMID: 25756685
-
The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.PLoS One. 2017 Feb 10;12(2):e0171704. doi: 10.1371/journal.pone.0171704. eCollection 2017. PLoS One. 2017. PMID: 28187173 Free PMC article.
-
Standardized assessment of the signal intensity increase on unenhanced T1-weighted images in the brain: the European Gadolinium Retention Evaluation Consortium (GREC) Task Force position statement.Eur Radiol. 2019 Aug;29(8):3959-3967. doi: 10.1007/s00330-018-5803-6. Epub 2018 Nov 9. Eur Radiol. 2019. PMID: 30413951 Review.
Cited by
-
T1 hyperintensity on brain imaging subsequent to gadolinium-based contrast agent administration: what do we know about intracranial gadolinium deposition?Br J Radiol. 2017 Jan;90(1069):20160590. doi: 10.1259/bjr.20160590. Epub 2016 Oct 19. Br J Radiol. 2017. PMID: 27653560 Free PMC article. Review.
-
Comprehensive Analysis of the Spatial Distribution of Gadolinium, Iron, Manganese, and Phosphorus in the Brain of Healthy Rats After High-Dose Administrations of Gadodiamide and Gadobutrol.Invest Radiol. 2024 Feb 1;59(2):150-164. doi: 10.1097/RLI.0000000000001054. Epub 2023 Dec 30. Invest Radiol. 2024. PMID: 38157437 Free PMC article.
-
Gadolinium Deposition in the Rat Brain Measured with Quantitative MRI versus Elemental Mass Spectrometry.Radiology. 2023 Jan;306(1):244-251. doi: 10.1148/radiol.212171. Epub 2022 Sep 20. Radiology. 2023. PMID: 36125373 Free PMC article.
-
The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study).AJNR Am J Neuroradiol. 2015 Sep;36(9):1589-98. doi: 10.3174/ajnr.A4468. Epub 2015 Jul 16. AJNR Am J Neuroradiol. 2015. PMID: 26185325 Free PMC article. Clinical Trial.
-
Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles.Histochem Cell Biol. 2021 Jan;155(1):19-73. doi: 10.1007/s00418-020-01919-0. Epub 2020 Oct 11. Histochem Cell Biol. 2021. PMID: 33040183
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical